Placebo News and Research

RSS
Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

Meta-analysis confirms complete failure of hydroxychloroquine/chloroquine as a COVID-19 treatment

Meta-analysis confirms complete failure of hydroxychloroquine/chloroquine as a COVID-19 treatment

BNT162b2 COVID vaccine 94% effective against adolescent hospitalization

BNT162b2 COVID vaccine 94% effective against adolescent hospitalization

Ketamine plus psychological therapy can help people stay off alcohol for longer time

Ketamine plus psychological therapy can help people stay off alcohol for longer time

Study shows probiotics can reduce symptoms of COVID-19 when taken post-exposure

Study shows probiotics can reduce symptoms of COVID-19 when taken post-exposure

Moderna announces initiation of Phase 1 study of its mRNA-1189 EBV vaccine candidate

Moderna announces initiation of Phase 1 study of its mRNA-1189 EBV vaccine candidate

FIND trial: Higher vitamin D intake does not affect mortality or cardiovascular disease, cancer risk

FIND trial: Higher vitamin D intake does not affect mortality or cardiovascular disease, cancer risk

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased oxygen saturation

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased oxygen saturation

Monoclonal antibody treatment of COVID-19 reduces viral shedding

Monoclonal antibody treatment of COVID-19 reduces viral shedding

New compound could combat multidrug-resistant pathogens in healthcare settings

New compound could combat multidrug-resistant pathogens in healthcare settings

Research demonstrates the safety, feasibility of psilocybin administered at doses of 10mg or 25mg

Research demonstrates the safety, feasibility of psilocybin administered at doses of 10mg or 25mg

Echinacea, a potent antiviral against SARS-CoV-2

Echinacea, a potent antiviral against SARS-CoV-2

New systematic review finds low-quality evidence on the effectiveness of hangover remedies

New systematic review finds low-quality evidence on the effectiveness of hangover remedies

A reliable assessment of COVID-19 vaccine protection duration

A reliable assessment of COVID-19 vaccine protection duration

Exploring immunogenicity and safety after a homologous booster dose of SARS-CoV-2 recombinant spike protein vaccine

Exploring immunogenicity and safety after a homologous booster dose of SARS-CoV-2 recombinant spike protein vaccine

Inhaled CBD shrinks glioblastoma’s size in an animal model

Inhaled CBD shrinks glioblastoma’s size in an animal model

Ad5-nCoV vaccine safe and effective against symptomatic, severe COVID-19, trials shows

Ad5-nCoV vaccine safe and effective against symptomatic, severe COVID-19, trials shows

Study points toward an alternative drug strategy to stall Alzheimer’s neurodegeneration

Study points toward an alternative drug strategy to stall Alzheimer’s neurodegeneration

Clinical trial results do not support the use of fish oil supplements to prevent depression

Clinical trial results do not support the use of fish oil supplements to prevent depression

Doctors advised to prescribe fewer antidepressants and for shorter periods of time

Doctors advised to prescribe fewer antidepressants and for shorter periods of time